Cargando…

Recurrent Graves’ disease post SARS-CoV-2 infection

A 22-year-old woman was diagnosed with thyrotoxicosis 8 weeks after the diagnosis of a mild COVID-19 infection. She had reported significant unexplained weight loss after testing positive for COVID-19, but failed to seek medical attention. She recovered well from COVID-19, but presented to the emerg...

Descripción completa

Detalles Bibliográficos
Autor principal: Montebello, Annalisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351485/
https://www.ncbi.nlm.nih.gov/pubmed/34362755
http://dx.doi.org/10.1136/bcr-2021-244714
_version_ 1783735983440658432
author Montebello, Annalisa
author_facet Montebello, Annalisa
author_sort Montebello, Annalisa
collection PubMed
description A 22-year-old woman was diagnosed with thyrotoxicosis 8 weeks after the diagnosis of a mild COVID-19 infection. She had reported significant unexplained weight loss after testing positive for COVID-19, but failed to seek medical attention. She recovered well from COVID-19, but presented to the emergency department with worsening symptoms of thyrotoxicosis after 2 months. In view of her known history of previously treated Graves’ disease, a recurrence of Graves’ thyrotoxicosis was suspected. A positive thyroid stimulating hormone receptor antibody confirmed the diagnosis. She was started on carbimazole and propranolol treatment with significant improvement of her symptoms.
format Online
Article
Text
id pubmed-8351485
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-83514852021-08-20 Recurrent Graves’ disease post SARS-CoV-2 infection Montebello, Annalisa BMJ Case Rep Case Report A 22-year-old woman was diagnosed with thyrotoxicosis 8 weeks after the diagnosis of a mild COVID-19 infection. She had reported significant unexplained weight loss after testing positive for COVID-19, but failed to seek medical attention. She recovered well from COVID-19, but presented to the emergency department with worsening symptoms of thyrotoxicosis after 2 months. In view of her known history of previously treated Graves’ disease, a recurrence of Graves’ thyrotoxicosis was suspected. A positive thyroid stimulating hormone receptor antibody confirmed the diagnosis. She was started on carbimazole and propranolol treatment with significant improvement of her symptoms. BMJ Publishing Group 2021-08-06 /pmc/articles/PMC8351485/ /pubmed/34362755 http://dx.doi.org/10.1136/bcr-2021-244714 Text en © BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ. https://bmj.com/coronavirus/usageThis article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.
spellingShingle Case Report
Montebello, Annalisa
Recurrent Graves’ disease post SARS-CoV-2 infection
title Recurrent Graves’ disease post SARS-CoV-2 infection
title_full Recurrent Graves’ disease post SARS-CoV-2 infection
title_fullStr Recurrent Graves’ disease post SARS-CoV-2 infection
title_full_unstemmed Recurrent Graves’ disease post SARS-CoV-2 infection
title_short Recurrent Graves’ disease post SARS-CoV-2 infection
title_sort recurrent graves’ disease post sars-cov-2 infection
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351485/
https://www.ncbi.nlm.nih.gov/pubmed/34362755
http://dx.doi.org/10.1136/bcr-2021-244714
work_keys_str_mv AT montebelloannalisa recurrentgravesdiseasepostsarscov2infection